NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹298 Cr | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹298 Cr |
| Mar2025 | ₹-211 Cr |
| Mar2024 | ₹-247 Cr |
| Mar2023 | ₹-363 Cr |
| Mar2022 | ₹35 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹298 Cr | Positive | |
| Mar2025 | ₹-211 Cr | Negative | |
| Mar2024 | ₹-247 Cr | Negative | |
| Mar2023 | ₹-363 Cr | Negative | |
| Mar2022 | ₹35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,579.3 Cr | -1.3% | -4.9% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.3% |
-4.9% |
-3.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses